Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.
about
Genetically modified mesenchymal stromal cells in cancer therapyUtilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injuryDiverging Concepts and Novel Perspectives in Regenerative Medicine.Spontaneous Recovery of Upper Extremity Motor Impairment After Ischemic Stroke: Implications for Stem Cell-Based Therapeutic Approaches.Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.The meteorology of cytokine storms, and the clinical usefulness of this knowledgeEndothelial progenitor cells transplantation attenuated blood-brain barrier damage after ischemia in diabetic mice via HIF-1α.Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients.Proteomic Analysis of a Rat Cerebral Ischemic Injury Model after Human Cerebral Endothelial Cell Transplantation.Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysisIntravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice.Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered.Factors affecting post-stroke motor recovery: Implications on neurotherapy after brain injury.Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy.Restoring brain function after stroke - bridging the gap between animals and humans.Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke.The long-term fate of mesenchymal stem cells labeled with magnetic resonance imaging-visible polymersomes in cerebral ischemia.Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic strokCellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.Potential Therapeutic Mechanisms and Tracking of Transplanted Stem Cells: Implications for Stroke Treatment.Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.Update on cell therapy for strokeTherapeutic Benefits of Mesenchymal Stromal Cells in a Rat Model of Hemoglobin-Induced Hypertensive Intracerebral Hemorrhage.Recent Advances in Stem Cell-Based Therapeutics for Stroke.Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design.Neuroregeneration: North America's First Human Stem Cell Trial for Stroke.Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants.Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence.What Do Language Disorders Reveal about Brain-Language Relationships? From Classic Models to Network Approaches.Cell Therapy in Stroke-Cautious Steps Towards a Clinical Treatment.Motor recovery beginning 23 years after ischemic stroke.Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate.Treatments to Promote Neural Repair after Stroke.Potential of Stem Cell-Based Therapy for Ischemic Stroke.Mesenchymal stem cells maintain the microenvironment of central nervous system by regulating the polarization of macrophages/microglia after traumatic brain injury.Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods.Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges.
P2860
Q28071840-FB91E7F0-4D4A-4015-8B90-8D476270032CQ28072473-3DCCF393-52FD-4F9B-B2EB-59B0FC399DD9Q33755185-E0445CFA-3FF5-44A3-BF55-405F59275EA6Q33861278-502C1155-667E-4C05-AC03-22A7BE6013E3Q33863549-27570E90-F268-4CE3-A00E-35F9451D0122Q33867213-828F3A8A-55E3-45F7-8B34-718AB39BEEFEQ33893649-A4F6C6AD-6967-4186-8149-8F40DDF88768Q33904790-45C7545A-B31C-41A1-954B-10B25F906C3BQ36193601-68F91A8D-4199-451E-9D7F-2A66E1B46952Q38601839-B9AA62A8-4AE7-4189-9E6D-6C64CF21F8A7Q38650671-F3370237-006C-45D7-984D-940980FAEF79Q38773427-B520AF83-0A33-4660-81BE-2FCF5CC99068Q38929267-C1CC2FEA-77E0-4696-9959-D307E0CCF87AQ39039084-CC68B365-152F-44FE-ADEE-FAC1A41FE068Q39183467-44DA60D2-5F06-4F1B-9F09-411CFC187423Q39457984-26EF5C0D-A3DC-4812-937E-1A20A88A7D3FQ41043653-7EA6CACE-8A8E-4E70-A84D-6990B1EDFE2DQ41089568-EDEAD6F7-F5D8-4B78-B0ED-6F071933940CQ41465830-63B19A6A-0B15-4796-B31C-83F981DA2FC4Q41572871-B081CC43-3090-4ACB-953B-361A207CDD7AQ41623285-E1C0F8C7-B475-48BF-9607-B2F3DCF326F4Q41653901-42B7803E-A577-46BE-88C2-9267BD690ABCQ41678510-29AFAAE8-5ADB-43C6-BD2C-DEEE48B50E55Q42318003-5BE181AA-510B-42F4-A080-A56E9906A92CQ44836823-05748B6C-E4EA-48AF-9B57-DBD6069244F5Q46125977-5A460445-1ED9-4569-A9CD-2027DA2E91E4Q46662726-7CF53E52-5D32-4D74-BA21-7D9D7FABA8E0Q47698235-66094B44-8A04-4CB5-9745-64D5C0B8C9D5Q47790688-25FFAD94-BC8C-4800-94BC-9B4B5D3C1463Q47804731-030C741A-65BF-4C2F-B772-94F6205880D3Q47833142-6A613A3D-1130-46BA-A242-9633B54FC1BBQ48130116-25F4977B-1716-474D-88DD-F0C36745A6E5Q48337519-8BE12B6D-6F0D-4F29-8098-76B481031879Q49905713-720B1EB3-8C9D-4760-86DA-B1BF20FB8D4CQ50062335-068D3055-562D-4CBC-9026-B79A78A33B84Q50238514-7C544756-D747-409F-B879-55254B5CD6B3Q51024048-5E619DBB-04FC-4639-9147-22F467BBC10CQ52594563-120DE53D-E0FC-497E-8113-5ABFEAAA072EQ52653941-52BE91E1-68B6-419C-B11B-1801788E2F40Q53476373-B1A95B34-D380-46C4-8756-FC4FFC819DEB
P2860
Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical Outcomes of Transplan ...... in Stroke: A Phase 1/2a Study.
@en
type
label
Clinical Outcomes of Transplan ...... in Stroke: A Phase 1/2a Study.
@en
prefLabel
Clinical Outcomes of Transplan ...... in Stroke: A Phase 1/2a Study.
@en
P2093
P2860
P1433
P1476
Clinical Outcomes of Transplan ...... in Stroke: A Phase 1/2a Study.
@en
P2093
Anthony S Kim
Casey Case
Damien Bates
Ernest W Yankee
Gary K Steinberg
Jeremiah N Johnson
Julia B Billigen
L Dade Lunsford
Lawrence R Wechsler
P2860
P304
P356
10.1161/STROKEAHA.116.012995
P407
P577
2016-06-02T00:00:00Z